Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura

שנת פרסום ראשונה: ינואר 2010
שנת עדכון:
מפרסם: BLOOD

Treatment options for patients with chronic refractory immune thrombocytopenic
purpura (ITP) are limited. Because combination immunosuppressant therapy
appeared to be effective in ITP and other disorders, we used this approach in patients
with particularly severe and refractory ITP.

BLOOD, 7 JANUARY 2010 , VOLUME 115, NUMBER 1